{"schema_version":"secwatch.filing_event.v1","accession":"0001664710-26-000005","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2026-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.805935+00:00","generated_at":"2026-05-16T02:06:06.228325+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Keros Therapeutics CEO to present at three healthcare conferences in Feb-Mar 2026","bullets":["Oppenheimer 36th Annual Healthcare Life Sciences Conference on Feb 25, 2026 at 11:20 a.m. ET (corporate presentation).","TD Cowen 46th Annual Health Care Conference on Mar 3, 2026 at 9:50 a.m. ET (fireside chat).","Leerink Partners Global Healthcare Conference on Mar 10, 2026 at 1:00 p.m. ET (fireside chat).","Archived replays available on Keros website for up to 90 days after each event."],"urls":{"canonical":"https://secwatch.observer/filing/0001664710-26-000005","json":"https://secwatch.observer/filing/0001664710-26-000005.json","markdown":"https://secwatch.observer/filing/0001664710-26-000005.md","text":"https://secwatch.observer/filing/0001664710-26-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000166471026000005/0001664710-26-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000166471026000005/kros-20260218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:06:06.228325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}